in the category

About locoregional recurrence risk after lipofilling in breast cancer patients.

The evidences from this study show that patients treated with lipofilling (22 patients, with a  follow-up of 3 years before and 3 years after lipofilling) show no recurrence of breast cancer.

This evidence let us to consider that the lipofilling is not a risk factor after surgery for ductal carcinoma in situ. On that basis we think that lipofilling is a safe procedure and that it can be used in every case, regardless of the histology of the tumor.

Semprini G, Cattin F, Lazzaro L, Cedolini C, Parodi PC. . Ann Oncol. 2012 Mar;23(3):802-3.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

In COMPLIANCE WITH ARTICLE 13 LEGISLATIVE DECREE 196/2003, we inform you that the data provided there filling this form will be processed by the Academy of Lipofilling in order to post your comments. The data may be treated with electronic and paper tools, in compliance with the Technical Regulations on Safety, Annex B to the Decree 196 / 2003. Your data will only be processed with your consent which is free and optional. Lack of consent lets unable to post. The Academy of Lipofilling directly manages the treatment through entities belonging to organization, or through external parties for the realization of the purposes previously indicated. These subjects will process your data in accordance with instructions received in quality of outsourcing or agents. The full list of the aforementioned subjects can be obtained directly from the Academy of Lipofilling based in Pesaro, Via Pantanelli 53, which is the data controller. Your data will not be subject to dissemination and they will only be kept for the time necessary to achievement of the aims set out above. As interested subject, you are entitled any time to exercise your rights under article 7 of Legislative Decree 196/2003 directing its request to the Owner who is the Academy of Lipofilling based in Pesaro via Pantanelli 53, in the shape of the President pro-tempore.Privacy PolicyI Accept The Terms and Privacy Policy